Cerenome, Inc. (CNSY)
0.6427
-0.03
(-4.06%)
USD |
NASDAQ |
Nov 06, 16:00
0.6601
+0.02
(+2.71%)
After-Hours: 20:00
Cerenome EPS Diluted (TTM) : -4.410 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.410 |
| March 31, 2026 | -3.267 |
| December 31, 2025 | -32.09 |
| September 30, 2025 | -47.60 |
| June 30, 2025 | -46.94 |
| March 31, 2025 | -47.05 |
| December 31, 2024 | -17.94 |
| September 30, 2024 | -2.236 |
| June 30, 2024 | -2.869 |
| March 31, 2024 | -3.186 |
| December 31, 2023 | -4.502 |
| September 30, 2023 | -6.185 |
| June 30, 2023 | -8.040 |
| March 31, 2023 | -11.01 |
| December 31, 2022 | -11.81 |
| September 30, 2022 | -13.30 |
| June 30, 2022 | -14.66 |
| March 31, 2022 | -14.82 |
| December 31, 2021 | -16.88 |
| September 30, 2021 | -23.81 |
| June 30, 2021 | -25.49 |
| March 31, 2021 | -28.58 |
| December 31, 2020 | -27.84 |
| September 30, 2020 | -12.70 |
| June 30, 2020 | -7.318 |
| Date | Value |
|---|---|
| March 31, 2020 | -96.81 |
| December 31, 2019 | -167341.1 |
| September 30, 2019 | -173316.6 |
| June 30, 2019 | -183678.3 |
| March 31, 2019 | -194707.7 |
| December 31, 2018 | -27984.19 |
| September 30, 2018 | -23512.87 |
| June 30, 2018 | -14200.69 |
| March 31, 2018 | -4500.00 |
| December 31, 2017 | -65850.00 |
| September 30, 2017 | -66150.00 |
| June 30, 2017 | -67050.00 |
| March 31, 2017 | -68850.00 |
| December 31, 2016 | -698846.6 |
| September 30, 2016 | -699296.6 |
| June 30, 2016 | -696221.6 |
| March 31, 2016 | -689621.6 |
| December 31, 2015 | -21375.00 |
| September 30, 2015 | -28125.00 |
| June 30, 2015 | -42750.00 |
| March 31, 2015 | -62999.99 |
| December 31, 2014 | -55124.99 |
| September 30, 2014 | -61874.99 |
| June 30, 2014 | -57374.99 |
| March 31, 2014 | -46125.00 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 19.80 |
| Ernexa Therapeutics, Inc. | -15.15 |
| ACADIA Pharmaceuticals, Inc. | 2.105 |
| Anika Therapeutics, Inc. | -0.1126 |
| Savara, Inc. | -0.5766 |